ANTI-CCP 05031656190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-09-10 for ANTI-CCP 05031656190 manufactured by Roche Diagnostics.

Event Text Entries

[26028322] It was noted that the customer has tested the sample at a different site on another e411 analyzer and the result was similar to the initial anti- ccp result of 38. 82 u/ml. The actual result was not provided.
Patient Sequence No: 1, Text Type: N, H10


[26131536] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[26131537] The customer complained of erroneous results for 1 patient sample tested for anti-ccp. The erroneous results were reported outside of the laboratory. The initial anti-ccp result was 38. 82 u/ml. This result was reported outside of the laboratory. The sample was sent to 2 external laboratories where the result from a siemens immulite analyzer was 1. 79 u/ml and the result from an abbott architect analyzer was 4. 80 u/ml. The sample was also repeated on another e411 system where the result was 45. 41 with a data flag. No adverse event was reported. The e411 system serial number was (b)(4). Preventative maintenance was last performed on 11/13/2014. During performance testing, the instrument was found to be out of specification by the field service engineer. Calibration was performed on 07/16/2015 when the reagent kit was loaded onto the system. The customer uses anti-ccp once a week and runs all samples every monday. It was noted that the customer uses biorad quality controls which do not have values for anti-ccp. The customer has set a range based on the values received over time and is using that range when running quality controls. The reagent kit was recalibrated on 08/21/2015 when the calibration signals seemed lower. After recalibrating, the signal dropped lower. The quality controls at this time were within the range set by the customer. It was noted that the calibration signals obtained by the customer were too low for both levels and calibration is not performed frequently enough based on manufacturer recommendations.
Patient Sequence No: 1, Text Type: D, B5


[28088287] Upon further investigation, various reagent and maintenance handling issues were discovered at the customer site. The customer is also using a control lot which is not specified for anti-ccp.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-04116
MDR Report Key5067028
Date Received2015-09-10
Date of Report2015-10-12
Date of Event2015-08-17
Date Mfgr Received2015-08-21
Date Added to Maude2015-09-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameANTI-CCP
Generic NameANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE
Product CodeNHX
Date Received2015-09-10
Model NumberNA
Catalog Number05031656190
Lot Number185555
ID NumberNA
Device Expiration Date2015-11-29
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-09-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.